These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting. Pérez-Medina C; Abdel-Atti D; Zhang Y; Longo VA; Irwin CP; Binderup T; Ruiz-Cabello J; Fayad ZA; Lewis JS; Mulder WJ; Reiner T J Nucl Med; 2014 Oct; 55(10):1706-11. PubMed ID: 25060196 [TBL] [Abstract][Full Text] [Related]
7. In Vitro and In Vivo Characterization of Allen KJH; Jiao R; Li J; Beckford-Vera DR; Dadachova E Molecules; 2022 Oct; 27(19):. PubMed ID: 36235126 [No Abstract] [Full Text] [Related]
8. ⁸⁹Zr-Labeled Versus ¹²⁴I-Labeled αHER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo. Mendler CT; Gehring T; Wester HJ; Schwaiger M; Skerra A J Nucl Med; 2015 Jul; 56(7):1112-8. PubMed ID: 25999431 [TBL] [Abstract][Full Text] [Related]
10. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies. Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418 [TBL] [Abstract][Full Text] [Related]
11. Positron Emission Tomography Imaging of Platelet-Derived Growth Factor Receptor β in Colorectal Tumor Xenograft Using Zirconium-89 Labeled Dimeric Affibody Molecule. Cai H; Shi Q; Tang Y; Chen L; Chen Y; Tao Z; Yang H; Xie F; Wu X; Liu N; Yang Y; Wu H; Tian R; Lu X; Li L Mol Pharm; 2019 May; 16(5):1950-1957. PubMed ID: 30986347 [TBL] [Abstract][Full Text] [Related]
12. ImmunoPET imaging of tissue factor expression in pancreatic cancer with Hernandez R; England CG; Yang Y; Valdovinos HF; Liu B; Wong HC; Barnhart TE; Cai W J Control Release; 2017 Oct; 264():160-168. PubMed ID: 28843831 [TBL] [Abstract][Full Text] [Related]
13. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice. Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484 [TBL] [Abstract][Full Text] [Related]
14. High-Density Lipoprotein Nanobiologics for Precision Medicine. Mulder WJM; van Leent MMT; Lameijer M; Fisher EA; Fayad ZA; Pérez-Medina C Acc Chem Res; 2018 Jan; 51(1):127-137. PubMed ID: 29281244 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, and biodistribution of multiple 89Zr-labeled pore-expanded mesoporous silica nanoparticles for PET. Miller L; Winter G; Baur B; Witulla B; Solbach C; Reske S; Lindén M Nanoscale; 2014 May; 6(9):4928-35. PubMed ID: 24675844 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer. Stergiou N; Nagel J; Pektor S; Heimes AS; Jäkel J; Brenner W; Schmidt M; Miederer M; Kunz H; Roesch F; Schmitt E Int J Med Sci; 2019; 16(9):1188-1198. PubMed ID: 31588183 [TBL] [Abstract][Full Text] [Related]
17. Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice. Karmani L; Labar D; Valembois V; Bouchat V; Nagaswaran PG; Bol A; Gillart J; Levêque P; Bouzin C; Bonifazi D; Michiels C; Feron O; Grégoire V; Lucas S; Vander Borght T; Gallez B Contrast Media Mol Imaging; 2013; 8(5):402-8. PubMed ID: 23740810 [TBL] [Abstract][Full Text] [Related]
18. Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe. Ahmed M; Tegnebratt T; Tran TA; Lu L; Damberg P; Gisterå A; Tarnawski L; Bone D; Hedin U; Eriksson P; Holmin S; Gustafsson B; Caidahl K Int J Nanomedicine; 2020; 15():6137-6152. PubMed ID: 32884268 [TBL] [Abstract][Full Text] [Related]
19. A generic Li N; Yu Z; Pham TT; Blower PJ; Yan R Int J Nanomedicine; 2017; 12():3281-3294. PubMed ID: 28458546 [TBL] [Abstract][Full Text] [Related]